{"id":309,"date":"2020-01-02T19:28:17","date_gmt":"2020-01-02T19:28:17","guid":{"rendered":"https:\/\/wwwtest.pharmacy.wisc.edu\/faculty\/hong-research-group\/?p=309"},"modified":"2025-06-20T19:31:52","modified_gmt":"2025-06-20T19:31:52","slug":"nanoparticle-conjugation-stabilizes-and-multimerizes-%ce%b2-hairpin-peptides-to-effectively-target-pd-1-pd-l1-%ce%b2-sheet-rich-interfaces","status":"publish","type":"post","link":"https:\/\/pharmacy.wisc.edu\/faculty\/hong-research-group\/2020\/01\/02\/nanoparticle-conjugation-stabilizes-and-multimerizes-%ce%b2-hairpin-peptides-to-effectively-target-pd-1-pd-l1-%ce%b2-sheet-rich-interfaces\/","title":{"rendered":"Nanoparticle Conjugation Stabilizes and Multimerizes \u03b2-Hairpin Peptides To Effectively Target PD-1\/PD-L1 \u03b2-Sheet-Rich Interfaces"},"content":{"rendered":"
\u03b2-Hairpin peptides present great potential as antagonists against \u03b2-sheet-rich protein surfaces, of which wide and flat geometries are typically \u201cundruggable\u201d with small molecules. Herein, we introduce a peptide\u2013dendrimer conjugate (PDC) approach that stabilizes the \u03b2-hairpin structure of the peptide via intermolecular forces and the excluded volume effect as well as exploits the multivalent binding effect. Because of the synergistic advantages, the PDCs based on a \u03b2-hairpin peptide isolated from an engineered programmed death-1 (PD-1) protein showed significantly higher affinity (avidity) to their binding counterpart, programmed death-ligand 1 (PD-L1), as compared to free peptides (by up to 5 orders of magnitude). The enhanced binding kinetics with high selectivity was translated into an improved immune checkpoint inhibitory effect in vitro, at a level comparable to (if not better than) that of a full-size monoclonal antibody. The results demonstrate the potential of the PDC system as a novel class of inhibitors targeting \u03b2-strand-rich protein surfaces, such as PD-1 and PD-L1, displaying its potential as a new cancer immunotherapy platform.<\/p>\r\n
\r\n\r\n